-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KyYh4oSB70ju/6h0/7G3lmaEyzPvjOa3ilqxQ676FeCMQNuL1ab47F9WaFEk+pif NoPAdDq94rN6Qfa8NDHvVA== 0001104659-06-022286.txt : 20060404 0001104659-06-022286.hdr.sgml : 20060404 20060404213947 ACCESSION NUMBER: 0001104659-06-022286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060401 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABGENIX INC CENTRAL INDEX KEY: 0001052837 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943248826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5106086500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILLS GAYLE CENTRAL INDEX KEY: 0001280355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24207 FILM NUMBER: 06740393 BUSINESS ADDRESS: BUSINESS PHONE: 5102846500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 a4.xml 4 X0202 4 2006-04-01 1 0001052837 ABGENIX INC ABGX 0001280355 MILLS GAYLE 6701 KAISER DRIVE FREMONT CA 94555 0 1 0 0 SVP, Business Development Common Stock, par value $0.0001 per share 2006-04-01 4 D 0 989 22.50 D 0 D Non-Qualified Stock Option (right to buy) 23.68 2006-04-01 4 D 0 20325 D 2002-02-11 2012-02-11 Common Stock, par value $0.0001 per share 20325 0 D Incentive Stock Option (right to buy) 23.68 2006-04-01 4 D 0 3175 D 2002-02-11 2012-02-11 Common Stock, par value $0.0001 per share 3175 0 D Non-Qualified Stock Option (right to buy) 8.87 2006-04-01 4 D 0 75000 D 2003-04-02 2010-04-02 Common Stock, par value $0.0001 per share 75000 0 D Non-Qualified Stock Option (right to buy) 15.32 2006-04-01 4 D 0 32000 D 2004-01-14 2011-01-14 Common Stock, par value $0.0001 per share 32000 0 D Incentive Stock Option (right to buy) 9.52 2006-04-01 4 D 0 19375 D 2004-07-13 2011-07-13 Common Stock, par value $0.0001 per share 19375 0 D Non-Qualified Stock Option (right to buy) 9.52 2006-04-01 4 D 0 10625 D 2004-07-13 2011-07-13 Common Stock, par value $0.0001 per share 10625 0 D Incentive Stock Option (right to buy) 8.98 2006-04-01 4 D 0 13240 D 2005-01-19 2012-01-19 Common Stock, par value $0.0001 per share 13240 0 D Non-Qualified Stock Option (right to buy) 8.98 2006-04-01 4 D 0 66760 D 2005-01-19 2012-01-19 Common Stock, par value $0.0001 per share 66760 0 D 1/48 of the total shares subject to the option became exercisable on the one month anniversary of the first date exercisable and an additional 1/48 of the total shares subject to the option became exercisable each full month thereafter with the balance fully vesting on 4/1/2006. This option was converted into an option to acquire 6,300 shares of Amgen Inc. common stock at an exercise price of $76.39 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 984 shares of Amgen Inc. common stock at an exercise price of $76.39 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 23,250 shares of Amgen Inc. common stock at an exercise price of $28.62 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 9,920 shares of Amgen Inc. common stock at an exercise price of $49.42 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 6,006 shares of Amgen Inc. common stock at an exercise price of $30.71 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 3,293 shares of Amgen Inc. common stock at an exercise price of $30.71 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 4,104 shares of Amgen Inc. common stock at an exercise price of $28.97 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 20,695 shares of Amgen Inc. common stock at an exercise price of $28.97 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. /s/ George F. Fraley (Attorney-in-Fact) 2006-04-01 -----END PRIVACY-ENHANCED MESSAGE-----